BSEM
Price
$12.45
Change
+$0.20 (+1.63%)
Updated
Jul 10 closing price
Capitalization
204.49M
46 days until earnings call
CELU
Price
$2.16
Change
+$0.04 (+1.89%)
Updated
Jul 10 closing price
Capitalization
50.77M
Interact to see
Advertisement

BSEM vs CELU

Header iconBSEM vs CELU Comparison
Open Charts BSEM vs CELUBanner chart's image
BioStem Technologies
Price$12.45
Change+$0.20 (+1.63%)
Volume$41.38K
Capitalization204.49M
Celularity
Price$2.16
Change+$0.04 (+1.89%)
Volume$61.44K
Capitalization50.77M
BSEM vs CELU Comparison Chart in %
Loading...
BSEM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CELU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BSEM vs. CELU commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BSEM is a Hold and CELU is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 11, 2025
Stock price -- (BSEM: $12.45 vs. CELU: $2.16)
Brand notoriety: BSEM and CELU are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BSEM: 78% vs. CELU: 76%
Market capitalization -- BSEM: $204.49M vs. CELU: $50.77M
BSEM [@Biotechnology] is valued at $204.49M. CELU’s [@Biotechnology] market capitalization is $50.77M. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BSEM’s FA Score shows that 0 FA rating(s) are green whileCELU’s FA Score has 0 green FA rating(s).

  • BSEM’s FA Score: 0 green, 5 red.
  • CELU’s FA Score: 0 green, 5 red.
According to our system of comparison, CELU is a better buy in the long-term than BSEM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BSEM’s TA Score shows that 3 TA indicator(s) are bullish while CELU’s TA Score has 7 bullish TA indicator(s).

  • BSEM’s TA Score: 3 bullish, 6 bearish.
  • CELU’s TA Score: 7 bullish, 2 bearish.
According to our system of comparison, CELU is a better buy in the short-term than BSEM.

Price Growth

BSEM (@Biotechnology) experienced а +4.27% price change this week, while CELU (@Biotechnology) price change was +9.09% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10.19%. For the same industry, the average monthly price growth was +16.32%, and the average quarterly price growth was +20.67%.

Reported Earning Dates

BSEM is expected to report earnings on Aug 26, 2025.

CELU is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (+10.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BSEM($204M) has a higher market cap than CELU($50.8M). CELU YTD gains are higher at: 3.846 vs. BSEM (-10.043). BSEM has higher annual earnings (EBITDA): -8.62M vs. CELU (-21.59M). CELU has more cash in the bank: 133K vs. BSEM (110K). BSEM has less debt than CELU: BSEM (6.02M) vs CELU (69.1M). CELU has higher revenues than BSEM: CELU (48.2M) vs BSEM (6.04M).
BSEMCELUBSEM / CELU
Capitalization204M50.8M402%
EBITDA-8.62M-21.59M40%
Gain YTD-10.0433.846-261%
P/E Ratio8.47N/A-
Revenue6.04M48.2M13%
Total Cash110K133K83%
Total Debt6.02M69.1M9%
FUNDAMENTALS RATINGS
BSEM vs CELU: Fundamental Ratings
BSEM
CELU
OUTLOOK RATING
1..100
6069
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
54
Fair valued
PROFIT vs RISK RATING
1..100
56100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
5949
P/E GROWTH RATING
1..100
65100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CELU's Valuation (54) in the null industry is in the same range as BSEM (56). This means that CELU’s stock grew similarly to BSEM’s over the last 12 months.

BSEM's Profit vs Risk Rating (56) in the null industry is somewhat better than the same rating for CELU (100). This means that BSEM’s stock grew somewhat faster than CELU’s over the last 12 months.

CELU's SMR Rating (99) in the null industry is in the same range as BSEM (100). This means that CELU’s stock grew similarly to BSEM’s over the last 12 months.

CELU's Price Growth Rating (49) in the null industry is in the same range as BSEM (59). This means that CELU’s stock grew similarly to BSEM’s over the last 12 months.

BSEM's P/E Growth Rating (65) in the null industry is somewhat better than the same rating for CELU (100). This means that BSEM’s stock grew somewhat faster than CELU’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BSEMCELU
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
78%
Momentum
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
71%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
81%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
72%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
73%
Advances
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
81%
Declines
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 4 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 2 days ago
80%
Aroon
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
BSEM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CELU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PJHRX30.09N/A
N/A
PGIM Jennison Health Sciences R
FVRLX6.27N/A
N/A
Forester Value R
VVOSX22.69N/A
N/A
Invesco Value Opportunities R6
SMYSX26.79N/A
N/A
Franklin Global Equity IS
CCGEX14.09-0.09
-0.63%
Calamos Global Equity C

BSEM and

Correlation & Price change

A.I.dvisor tells us that BSEM and VTYX have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BSEM and VTYX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BSEM
1D Price
Change %
BSEM100%
+1.63%
VTYX - BSEM
22%
Poorly correlated
+18.33%
ABSI - BSEM
20%
Poorly correlated
-3.53%
AURA - BSEM
20%
Poorly correlated
+2.73%
CELU - BSEM
20%
Poorly correlated
+1.89%
CLVLY - BSEM
11%
Poorly correlated
-6.14%
More

CELU and

Correlation & Price change

A.I.dvisor tells us that CELU and FATE have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CELU and FATE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CELU
1D Price
Change %
CELU100%
+1.89%
FATE - CELU
27%
Poorly correlated
+0.87%
PRAX - CELU
27%
Poorly correlated
+0.20%
RNAC - CELU
26%
Poorly correlated
-1.67%
SAGE - CELU
26%
Poorly correlated
+0.11%
CYBN - CELU
26%
Poorly correlated
+1.06%
More